Results 1 to 10 of about 12,406 (149)

Development of MenFive®, an affordable pentavalent meningococcal conjugate vaccine (ACYWX) for Africa and beyond [PDF]

open access: yesHuman Vaccines & Immunotherapeutics
Wide use of the groundbreaking vaccine MenAfriVac® has eliminated serogroup A meningococcal meningitis in the African meningitis belt and paved the way for elimination of all meningococcal disease outbreaks with the development, licensure, and ...
Mark R. Alderson   +7 more
doaj   +2 more sources

Is meningococcal B vaccination needed in the post-COVID-19 world? [PDF]

open access: yesBiomédica: revista del Instituto Nacional de Salud
Neisseria meningitidis is the main cause of bacterial meningitis worldwide and is transmitted through respiratory secretions. Meningitis is a serious public health problema because of its high morbidity and mortality rates and the risk of causing ...
Amanda Izeli Portilho   +1 more
doaj   +2 more sources

An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine [PDF]

open access: yesNovel Research in Microbiology Journal, 2021
Meningitis is an inflammation of the meninges, which are the three membranes that cover the brain and the spinal cord; which occurs when the fluid surrounding the meninges becomes infected.
Asmaa Alrobai   +2 more
doaj   +1 more source

Neisseria Meningitidis Causing Multiple Cerebral Abscesses in Early Neonatal Period: Case Report and Review of Literature [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Neisseria meningitidis is a rare cause of meningitis and septicemia in neonates. There are few published case reports of neonatal meningococcal meningitis complicated by subdural empyema, cerebral abscess and hydrocephalus.
LAXMAN BASANI, ROJA AEPALA
doaj   +1 more source

Meningococcal vaccines in China

open access: yesHuman Vaccines & Immunotherapeutics, 2021
Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines.
Yinghua Xu   +5 more
doaj   +1 more source

Pediatric bacterial meningitis and meningococcal disease profile in a Brazilian General Hospital

open access: yesBrazilian Journal of Infectious Diseases, 2020
Objective: To evaluate the clinical and epidemiological profile of bacterial meningitis and meningococcal disease in pediatric patients admitted to a Brazilian Secondary Public Hospital.
Bruna P. Blanco   +3 more
doaj   +1 more source

Neisseria meningitidis pneumonia with bacteremia without meningitis: An atypical presentation

open access: yesIDCases, 2020
Neisseria meningitidis remains the most important cause of bacterial meningitis worldwide. The second most common and potentially severe end-organ manifestation of invasive meningococcal disease is meningococcal pneumonia.
Fatma Mohamed Mahmoud, Thana Harhara
doaj   +1 more source

Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Neisseria meningitidis Isolated from 2009 to 2013 in the Republic of Ireland

open access: yesmSphere, 2018
Neisseria meningitidis is a common cause of bacterial meningitis in children and young adults worldwide. The 4CMenB vaccine (Bexsero), developed to combat meningococcal serogroup B (MenB) disease, contains subcapsular antigens that may induce immunity ...
Robert M. Mulhall   +12 more
doaj   +1 more source

Current status and challenges of meningococcal vaccines development in China

open access: yesZhongguo gonggong weisheng, 2022
Vaccination is the most effective and economical way to prevent meningococcal meningitis. In the past few decades, with widespread use of meningococcal vaccines, the incidence of meningococcal meningitis has dropped significantly. There are some vaccines
Ying-hua XU, Ya-nan LI, Qiang YE
doaj   +1 more source

Bacterial Meningitis in Brazil: Baseline Epidemiologic Assessment of the Decade Prior to the Introduction of Pneumococcal and Meningococcal Vaccines. [PDF]

open access: yesPLoS ONE, 2013
Bacterial meningitis is associated with significant burden in Brazil. In 2010, both 10-valent pneumococcal conjugate vaccine and meningococcal capsular group C conjugate vaccine were introduced into the routine vaccination schedule.
Luciano Cesar Pontes Azevedo   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy